Clinical Trials Directory

Trials / Completed

CompletedNCT03320187

Nitroglycerin Skin Patches for Facilitating Cervical Ripening: A Randomized Controlled Trial

NITROGLYCERINE SKIN PATCH VS PLACEBO PATCH FOR ENHANCING CERVICAL RIPENING IN LABOR INDUCTION: A RANDOMIZED CONTROLLED TRIAL

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Ain Shams Maternity Hospital · Academic / Other
Sex
Female
Age
17 Years – 35 Years
Healthy volunteers
Accepted

Summary

This study aims to establish the efficacy of transdermal glyceryl trinitrate as a nitric oxide donor in addition to dinoprostone for induction of cervical ripening in the third trimester through progression in the Bishop's score during 24 hour period.

Detailed description

Objectives: The primary outcome of the study is to compare the changes occurring to the cervix through the progression in the Bishop's score between NO donor (nitroglycerine patch) vs placebo; in combination with a well-established method of induction (Dinoprostone). The secondary objective of the study is to observe and report possible fetal and maternal side effects that may be associated. This will establish the safety and tolerability of NO donors. Research Question: Does the usage of Nitroglycerine skin patch enhance cervical ripening and facilitate induction of labor by Dinoprostone? Null hypothesis: Nitroglycerine skin patch does not cause advantage for ripening of the cervix nor facilitate the process of labor induction. Alternative hypothesis : Nitroglycerine skin patch has favorable effect in enhancing cervical ripening and the outcome of induction of labor.

Conditions

Interventions

TypeNameDescription
DRUGNitroderm TTSTransdermal nitroglycerin 5mg skin patch
DRUGDinoprostoneDinoprostone 3gm vaginal tablet will be used as the study method of labor induction

Timeline

Start date
2016-12-01
Primary completion
2017-09-01
Completion
2017-09-21
First posted
2017-10-25
Last updated
2017-10-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03320187. Inclusion in this directory is not an endorsement.